High Risk Population Isolate Reveals Low Frequency Variants Predisposing to Intracranial Aneurysms

English version České info

3% of the population develops saccular intracranial aneurysms (sIAs), a complex trait, with a sporadic and a familial form. Subarachnoid hemorrhage from sIA (sIA-SAH) is a devastating form of stroke. Certain rare genetic variants are enriched in the Finns, a population isolate with a small founder population and bottleneck events. As the sIA-SAH incidence in Finland is >2× increased, such variants may associate with sIA in the Finnish population. We tested 9.4 million variants for association in 760 Finnish sIA patients (enriched for familial sIA), and in 2,513 matched controls with case-control status and with the number of sIAs. The most promising loci (p<5E-6) were replicated in 858 Finnish sIA patients and 4,048 controls. The frequencies and effect sizes of the replicated variants were compared to a continental European population using 717 Dutch cases and 3,004 controls. We discovered four new high-risk loci with low frequency lead variants. Three were associated with the case-control status: 2q23.3 (MAF 2.1%, OR 1.89, p 1.42×10-9); 5q31.3 (MAF 2.7%, OR 1.66, p 3.17×10-8); 6q24.2 (MAF 2.6%, OR 1.87, p 1.87×10-11) and one with the number of sIAs: 7p22.1 (MAF 3.3%, RR 1.59, p 6.08×-9). Two of the associations (5q31.3, 6q24.2) replicated in the Dutch sample. The 7p22.1 locus was strongly differentiated; the lead variant was more frequent in Finland (4.6%) than in the Netherlands (0.3%). Additionally, we replicated a previously inconclusive locus on 2q33.1 in all samples tested (OR 1.27, p 1.87×10-12). The five loci explain 2.1% of the sIA heritability in Finland, and may relate to, but not explain, the increased incidence of sIA-SAH in Finland. This study illustrates the utility of population isolates, familial enrichment, dense genotype imputation and alternate phenotyping in search for variants associated with complex diseases.

Vyšlo v časopise: High Risk Population Isolate Reveals Low Frequency Variants Predisposing to Intracranial Aneurysms. PLoS Genet 10(1): e32767. doi:10.1371/journal.pgen.1004134
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1004134

Souhrn

Zdroje

1. VlakMH, AlgraA, BrandenburgR, RinkelGJ (2011) Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol 10: 626–636.

2. RonkainenA, MiettinenH, KarkolaK, PapinahoS, VanninenR, et al. (1998) Risk of harboring an unruptured intracranial aneurysm. Stroke 29: 359–362.

3. Van GijnJ, KerrRS, RinkelGJE (2007) Subarachnoid haemorrhage. Lancet 369: 306–318.

4. FeiginVL, LawesCMM, BennettDA, Barker-ColloSL, ParagV (2009) Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 8: 355–369.

5. De RooijNK, LinnFHH, van der PlasJA, AlgraA, RinkelGJE (2007) Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry 78: 1365–1372.

6. FeiginVL, RinkelGJE, LawesCMM, AlgraA, BennettDA, et al. (2005) Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke 36: 2773–2780.

7. RonkainenA, HernesniemiJ, PuranenM, NiemitukiaL, VanninenR, et al. (1997) Familial intracranial aneurysms. Lancet 349: 380–384.

8. HuttunenT, von und zu FraunbergM, FrösenJ, LeheckaM, TrompG, et al. (2010) Saccular intracranial aneurysm disease: distribution of site, size, and age suggests different etiologies for aneurysm formation and rupture in 316 familial and 1454 sporadic eastern Finnish patients. Neurosurgery 66: 631–8 discussion 638.

9. RuigrokYM, BuskensE, RinkelGJ (2001) Attributable risk of common and rare determinants of subarachnoid hemorrhage. Stroke 32: 1173–1175.

10. YasunoK, BakirciogluM, LowS-K, BilgüvarK, GaálE, et al. (2011) Common variant near the endothelin receptor type A (EDNRA) gene is associated with intracranial aneurysm risk. Proc Natl Acad Sci U S A

11. LowS-K, TakahashiA, ChaP-C, ZembutsuH, KamataniN, et al. (2012) Genome-wide association study for intracranial aneurysm in the Japanese population identifies three candidate susceptible loci and a functional genetic variant at EDNRA. Hum Mol Genet 21: 2102–2110.

12. YasunoK, BilguvarK, BijlengaP, LowS-K, KrischekB, et al. (2010) Genome-wide association study of intracranial aneurysm identifies three new risk loci. Nat Genet 42: 420–425.

13. BilguvarK, YasunoK, NiemeläM, RuigrokYM, von Und Zu FraunbergM, et al. (2008) Susceptibility loci for intracranial aneurysm in European and Japanese populations. Nat Genet 40: 1472–1477.

14. The 1000 Genomes Project Consortium (2012) An integrated map of genetic variation from 1,092 human genomes. Nature 135: 0–9.

15. PeltonenL, Jalankoa, VariloT (1999) Molecular genetics of the Finnish disease heritage. Hum Mol Genet 8: 1913–1923.

16. RuigrokYM, RinkelGJE, AlgraA, RaaymakersTWM, Van GijnJ (2004) Characteristics of intracranial aneurysms in patients with familial subarachnoid hemorrhage. Neurology 62: 891–894.

17. MackeyJ (2012) Unruptured intracranial aneurysms in the Familial Intracranial Aneurysm and International Study of Unruptured Intracranial Aneurysms cohorts: differences in multiplicity and location. J Neurosurg 117: 192.

18. AkiyamaK, NaritaA, NakaokaH, CuiT, TakahashiT, et al. (2010) Genome-wide association study to identify genetic variants present in Japanese patients harboring intracranial aneurysms. J Hum Genet 55: 656–661.

19. WardLD, KellisM (2012) HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res 40: D930–4.

20. ErnstJ, KheradpourP, MikkelsenTS, ShoreshN, LucasD, et al. (2011) Systematic analysis of chromatin state dynamics in nine human cell types. Nature 473: 43–49.

21. LappalainenT, SammethM, FriedländerMR, 't Hoen P aC, MonlongJ, et al. (2013) Transcriptome and genome sequencing uncovers functional variation in humans. Nature 501: 506–511.

22. SulemP, GudbjartssonDF, WaltersGB, HelgadottirHT, HelgasonA, et al. (2011) Identification of low-frequency variants associated with gout and serum uric acid levels. Nat Genet 43: 1127–1130.

23. JonssonT, StefanssonH, SteinbergS, JonsdottirI, Jonsson PV, et al. (2013) Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med 368: 107–116.

24. ZhangY, LangQ, LiJ, XieF, WanB, et al. (2010) Identification and characterization of human LYPD6, a new member of the Ly-6 superfamily. Mol Biol Rep 37: 2055–2062.

25. NigroP, AbeJ-I, BerkBC (2011) Flow shear stress and atherosclerosis: a matter of site specificity. Antioxid Redox Signal 15: 1405–1414.

26. KurkiMI, HäkkinenSK, FrösenJ, TulamoR, FraunbergM, et al. (2011) Upregulated signaling pathways in ruptured human saccular intracranial aneurysm wall: an emerging regulative role of Toll like receptor signaling and NF-κB, HIF1A and ETS transcription factors. Neurosurgery 68: 1667–1676.

27. Lerner-ellisJP, RosenblattDS, NewboldRF, BaumgartnerMR, FowlerB (2008) Gene Identification for the cblD Defect of Vitamin B12 Metabolism. N Engl J Med 358: 1454–1464.

28. MurakamiK, TanakaM, UsuiT, KawabataD, ShiomiA, et al. (2012) Follistatin-related protein/follistatin-like 1 evokes an innate immune response via CD14 and toll-like receptor 4. FEBS Lett 586: 319–324.

29. Lara-PezziE, FelkinLE, BirksEJ, SarathchandraP, PanseKD, et al. (2008) Expression of follistatin-related genes is altered in heart failure. Endocrinology 149: 5822–5827.

30. GorelikM, WilsonDC, CloonanYK, ShulmanST, HirschR (2012) Plasma follistatin-like protein 1 is elevated in Kawasaki disease and may predict coronary artery aneurysm formation. J Pediatr 161: 116–119.

31. LukeMM, O'MearaES, RowlandCM, ShiffmanD, Bare La, et al. (2009) Gene variants associated with ischemic stroke: the cardiovascular health study. Stroke 40: 363–368.

32. GuoY, TomlinsonB, ChuT, FangYJ, GuiH, et al. (2012) A genome-wide linkage and association scan reveals novel loci for hypertension and blood pressure traits. PLoS One 7: e31489.

33. MinassianBA, LeeJR, HerbrickJA, HuizengaJ, SoderS, et al. (1998) Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat Genet 20: 171–174.

34. GentryMS, Romá-MateoC, SanzP (2013) Laforin, a protein with many faces: glucan phosphatase, adapter protein, et alii. FEBS J 280: 525–537.

35. AhmedSM, DaulatAM, MeunierA, AngersS (2010) G protein betagamma subunits regulate cell adhesion through Rap1a and its effector Radil. J Biol Chem 285: 6538–6551.

36. LiuL, AerbajinaiW, AhmedSM, RodgersGP, AngersS, et al. (2012) Radil controls neutrophil adhesion and motility through β2-integrin activation. Mol Biol Cell 23(24): 4751–65.

37. FrösenJ, TulamoR, PaetauA, LaaksamoE, KorjaM, et al. (2012) Saccular intracranial aneurysm: pathology and mechanisms. Acta Neuropathol 123(6): 773–86.

38. EliasonJL, HannawaKK, AilawadiG, SinhaI, FordJW, et al. (2005) Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation. Circulation 112: 232–240.

39. HelgadottirA, ThorleifssonG, MagnussonKP, GrétarsdottirS, SteinthorsdottirV, et al. (2008) The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet 40: 217–224.

40. WellcomeT, CaseT, ConsortiumC (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661–678.

41. JohnsonAD, HwangS-J, VoormanA, MorrisonA, PelosoGM, et al. (2013) Resequencing and clinical associations of the 9p21.3 region: a comprehensive investigation in the framingham heart study. Circulation 127: 799–810.

42. StefanssonB, OhamaT, DaughertyAE, BrautiganDL (2008) Protein phosphatase 6 regulatory subunits composed of ankyrin repeat domains. Biochemistry 47: 1442–1451.

43. StefanssonB, BrautiganDL (2007) Protein phosphatase PP6 N terminal domain restricts G1 to S phase progression in human cancer cells. Cell Cycle 6: 1386–1392.

44. StefanssonB, BrautiganDL (2006) Protein phosphatase 6 subunit with conserved Sit4-associated protein domain targets IkappaBepsilon. J Biol Chem 281: 22624–22634.

45. TomohiroAoki, HiroharuKataoka, MunehisaShimamura, HironoriNakagami, KoujiWakayama, et al. (2007) NF-B Is a Key Mediator of Cerebral Aneurysm Formation. Circulation 116: 2830.

46. BarkerDJP, OsmondC, ForsénTJ, KajantieE, ErikssonJG (2005) Trajectories of growth among children who have coronary events as adults. N Engl J Med 353: 1802–1809.

47. Aromaa A, Koskinen S, editors (2004) HEALTH AND FUNCTIONAL CAPACITY IN FINLAND. Baseline Results of the Health 2000 Health Examination Survey. Publications of the National Public Health Institute.

48. THL - National Institute for Health and Welfare. (2000) Health (2000). Available: http://www.terveys2000.fi/indexe.html. Accessed 22 January 2013.

49. PurcellS, NealeB, ToddbrownK, ThomasL, FerreiraM, et al. (2007) PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses. Am J Hum Genet 81: 559–575.

50. RaitakariOT, JuonalaM, RönnemaaT, Keltikangas-JärvinenL, RäsänenL, et al. (2008) Cohort profile: the cardiovascular risk in Young Finns Study. Int J Epidemiol 37: 1220–1226.

51. The Cardiovascular Risk in Young Finns Study (2008). Available: http://vanha.med.utu.fi/cardio/youngfinnsstudy/index.html. Accessed 22 January 2013.

52. VartiainenE, LaatikainenT, PeltonenM, JuoleviA, MännistöS, et al. (2010) Thirty-five-year trends in cardiovascular risk factors in Finland. Int J Epidemiol 39: 504–518.

53. WetzelsJFM, KiemeneyLA, SwinkelsDW, WillemsHL, den HeijerM (2007) Age- and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int 72: 632–637.

54. KiemeneyLA, ThorlaciusS, SulemP, GellerF, AbenKKH, et al. (2008) Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet 40: 1307–1312.

55. HowieB, FuchsbergerC, StephensM, MarchiniJ, AbecasisGR (2012) Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet 44: 955–959.

56. DelaneauO, MarchiniJ, ZaguryJ-F (2012) A linear complexity phasing method for thousands of genomes. Nat Methods 9: 179–181.

57. HowieBN, DonnellyP, MarchiniJ (2009) A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet 5: e1000529.

58. PruimRJ, WelchRP, SannaS, TeslovichTM, ChinesPS, et al. (2010) LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26: 2336–2337.

59. VuongQH (1989) LIkelihood Ratio Tests for Model Selection and Non-Nested Hypotheses. Econometrica 57: 307–333.

60. HigginsJPT, ThompsonSG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539–1558.

61. ViechtbauerW (2010) Conducting Meta-Analyses in R with the metafor Package. J Stat Softw 36.

62. SoH-C, GuiAHS, ChernySS, ShamPC (2011) Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases. Genet Epidemiol 35: 310–317.